About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials | 1,265 Studies Recruiting

Clinical TrialsLupus

Lupus Clinical Trials

Browse 1,265 clinical trials for lupus. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1221-1240 of 1,265 trials

SuspendedA First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy ParticipantsThis is a first time in human (FTiH) study which means that this is the first time that GSK4347859 is given to humans.NCT06188507·Cambridge and 1 other UnknownNature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLEThis study to examines the impact of anifrolumab on disease activity, immune phenotypes, and development of neutralizing antibodies to quadrivalent influenza vaccine in patients…NCT04726553·New Haven, Connecticut and 4 others RecruitingA Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE.NCT07409181·Beverly Hills, California and 139 others

Related Searches

sletrials systemic lupustrials

Data from ClinicalTrials.govTerms

CompletedFolateScan in Autoimmune DiseaseThis study will gather information on the safety of FolateScan and the ability of FolateScan to detect inflammation in the joints and other organs in people with arthritis…NCT00588393·Rochester, Minnesota

CompletedInduction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesTRANSREG will assess the safety and biological efficacy of low-dose IL2 as a Treg inducer in a set of 14 autoimmune and auto-inflammatory diseases, with the aim to select diseases…NCT01988506·Créteil and 10 others

CompletedLow-dose IL-2( Interleukin-2) Treatment in SLEThis clinical study will test the efficacy and safety of low dose IL-2 treatment in Systemic lupus erythematosus.NCT02084238·Beijing, Beijing Municipality

CompletedValidation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus ErythematosusSystemic lupus erythematosus (SLE) may involve a variety of organ systems expressed differently from patient to patient, and so can be difficult to characterize clinically.NCT03142711·Atlanta, Georgia and 9 others

WithdrawnClinical Performance of BioCLIA Ro60The study is to evaluate the clinical performance of BioCLIA Ro60 for measuring the autoantibody in autoimmune disease patients.NCT03204448·Irvine, California

CompletedA Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an AutoinjectorThe primary objective of this study is to assess the suitability of the autoinjector for self-administration of belimumab by subjects with SLE in real-life conditions.NCT02124798·Birmingham, Alabama and 26 others

CompletedStudy of VIB7734 for the Treatment of Moderate to Severely Active SLEA Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus in…NCT04925934·Upland, California and 66 others

TerminatedLUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLEThe purpose of this study is to investigate the effects of a type of non-invasive transcranial alternating current stimulation (tACS) on patients diagnosed with systemic lupus…NCT04141046·Chapel Hill, North Carolina

UnknownClinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus ErythematosusAim and objectives of this study * To summarize the main clinical characteristics of patients with jSLE admitted and followed up in Assiut University children's Hospital.NCT04645225

Active not recruitingA Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)The goal of this clinical trial is to learn about the safety, how the body processes the drug, and its effects of a drug called cenerimod in adult Chinese participants (aged…NCT07266090·Guangzhou, Guangdong and 6 others

RecruitingHEALTH Home Urinalysis TestingStudy participants enrolled in the SAMPLE Biorepository (s14-00487) who have provided permission to be contacted for future research will be enrolled and randomized (1:1) two-arm…NCT07823478·New York, New York

UnknownAssessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus.NCT06151990·Asyut

CompletedPrediction of Relapse Risk in Stable Systemic Lupus ErythematosusWhether and when systemic lupus erythematosus (SLE) patients with stable disease should withdraw glucocorticoid (GC)? How about the relapse risk?NCT02842814·Hefei, Anhui and 4 others

RecruitingA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.The purpose of this study is to measure the safety, tolerability, PK, and PD of AZD5492 administered subcutaneously in adult participants with SLE or IIM or RA Study details…NCT06916806·Anniston, Alabama and 36 others

UnknownRole of Altered CD40-Ligand Gene Transcription in Systemic Lupus ErythematosusSystemic lupus erythematosus is an often devastating autoimmune disease which affects 1 in 2,000 women in the United States.NCT00008749·Philadelphia, Pennsylvania

TerminatedLong-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)This is a multicenter, double-blind, Phase 2b, long-term extension (LTE) to the ADDRESS II core trial (EMR 700461-023) (NCT01972568), to evaluate long-term safety and tolerability…NCT02070978·Anniston, Alabama and 83 others

Active not recruitingLupus Arthritis: Muscoloskeletal Ultrasound as Clinical Outcome of Peripheral Blood and Synovial Deep PhenotypingMusculoskeletal involvement, defined as arthritis/arthralgia, is the most common manifestation of patients with systemic lupus erythematosus (SLE).NCT07102238·Rome, RM

PreviousPage 62 of 64Next